Hair Transplant Market 2021: Global Analysis, Business Strategy, Development Status, Emerging Technologies, Future Plans And Trends By Forecast 2027

Hair Transplant Market Overview

Market Research Future (MRFR) predicts the hair transplant market to garner a CAGR of 24 % over the evaluation period of 2017-2023. The market valuation is expected to be worth USD 23,881.9 million by 2023.

The surgical technique of transferring healthy hair follicle from the donor site to a bald site or recipient site is called hair transplantation.

The increasing concern about the aesthetic appeal is identified as a significant driving factor for the global hair transplant market.  The changing lifestyle is predicted to triggering the adoption of hair transplant among people. The high rate of success on surgical treatment is likely to bolster the growth of the hair transplant market over the review period. The high rate of hair restoration in males after surgery is also likely to shoot up the growth curve of the global hair transplant market. Strategic agreements, partnership, and mergers are also contributing to the expansion of the global hair transplant market growth. The immense possibilities is bolstering new product launches. This is creating scope for attracting investments for research and developmental activities. These activities are concerned with the enhancement of surgical techniques.  Hence, the market is gaining traction for generating revenues. This, in turn, is envisaged to escalate the global hair transplant market growth. 

Hair Transplant Market Segmental Analysis

The segmental analysis of the global hair transplant market provides a comprehensive understanding of the market. This helps in the identification of numerous growth opportunities. Thereby, influencing the market growth. The global hair transplant market study has been segmented based on type of surgery, surgical methods, and end-user.

Based on the surgery, the hair transplant market has been segmented into head hair transplant, eyebrow transplant, and frontal hairline lowering or reconstruction. The surgery segment is estimated to exhibit the fastest growth rate.

Based on surgical methods, the hair transplant market has been segmented into follicular unit transplantation and follicular unit extraction. The follicular unit transplantation segment is envisaged to secure the largest share in the market.

Based on the end-user, the hair transplant market has been segmented into dermatology, hospitals, and trichology clinic. 

Hair Transplant Market Regional Insights

The regional analysis of the hair transplant market provides information on the geographic progress of the market. Based on the region, the hair transplant market has been studied across the Americas, Europe, Asia Pacific, and the Middle East Asia and Africa.

The Americas is anticipated to lead in the global hair transplant market. Advancements in the hair transplant technologies and its high acceptance among people are anticipated to bolster the regional hair transplant market growth in the coming years. MRFR forecasts, the hair transplant market in the Asia Pacific region is to register a 24.3% CAGR over the assessment period. The presence of influential key players operating in the market, in the Asia Pacific region, is likely to foster the hair transplant market. The European hair transplant market is expected to be the fastest growing market and reach a valuation that is worth USD 3,647.3 million by 2023. The lack of awareness about hair transplantation in the Middle East Asia and African region is accounted for the moderate growth rate of the regional market. 

Browse Full Report with TOC at:

Hair Transplant Market Players

MRFR enlisted prominent companies operating in the hair transplant market. They are Restoration Robotics Inc. Company (US), Ethics hair instruments (India), Cole instruments (US), Bernstein Medical (US), MEDICAMAT (France), and Bosley (US). 

Hair Transplant Industry News

May 2019: Silicon Valley Hair Institute announced as the best hair transplant clinics in San Francisco, California.

Healthcare Claims Management Market Analysis By Development Status, Business Opportunities, Trends And Competitive Landscape

Healthcare Claims Management Market Highlights

The healthcare claims management market is expected to demonstrate a CAGR of 5.37% during the forecast period (2018–2023), as per the latest analysis by Market Research Future (MRFR).

Healthcare Claims Management Market Drivers and Top Barriers

Healthcare claims management software is used for managing medical claims as well as reimbursement processes, allowing the healthcare providers to elevate their revenues by efficient claim management. In essence, healthcare claims management refers to a bilateral process between healthcare providers, patients, insurance provider, and the billing company. On account of the quick rate of expansion of the healthcare insurance sector in recent years, the healthcare claims management market is expanding rapidly.

Across the world, the healthcare claims management market is expanding at a significant pace predominantly owing to the burgeoning geriatric population, growing incidences of chronic diseases, elevated focus on healthcare quality services, and the emergence of inventive treatments as well as technologies. The increasing digitization coupled with the booming healthcare information technology (IT) market contributes considerably to the mounting market credentials. The expanding population mandates the need for high quality of coordinated care. The ever-expanding administrative as well as operational expenses in the healthcare industry leads to the need for cost-effective management of claims. As claims management provide practical solutions, compared to the traditional paper-based systems, the demand is set to escalate and influence the market positively in the future.

Some other crucial factors deciding the success rate of the market include the quickly growing healthcare infrastructure along with the increasing uptake of solutions that help manage the rising claims in the healthcare industry. On top of this, the technological advancements brought on by enhanced funding and favorable economic conditions are nurturing the growth of the healthcare claims management market.

Healthcare Claims Management Market Segmentation

The global market for healthcare claims management is segmented on the basis of component, delivery mode type and end-user.

The component-based segments in the market are software and services.

The modes of delivery covered by the report are on-premise and cloud based.

Type-wise, the market is considered for integrated and standalone.

The market, depending on the end-user, has been segmented based on healthcare payers and providers. 

Healthcare Claims Management Market Regional Insight

Asia Pacific, Europe, North America, and the Rest-of-the-World are among the prominent regions where the global healthcare claims management market is set to expand in the near future.

The North America heads the global healthcare claims management market, backed by the sophisticated healthcare industry and favorable government policies. Also, the growing adoption of claim management solutions to avail growth in incentives is expected to stimulate the market growth in the region. In addition to this, the increasing investments within healthcare information technology (HCIT) combined with the presence of regulatory mandates encouraging the use of healthcare claims management solutions also lays a strong foundation for the market. The United States (US) and Canada are among the most profitable countries within the region, successfully implementing healthcare IT, as a result of which the regional market has advanced to considerable heights in recent years. Furthermore, surge in favorable government initiatives, regulatory framework, and innovations in this field have driven the market expansion to a large extent.

Europe has bagged the second position in the global healthcare claims management market, owing to the increase in digitization in conjunction with the rising focus on data integration as well as data governance for the elevated number of claims within the healthcare industry.

The claims management market in Asia Pacific benefits largely by the advancements in technology as well as the healthcare infrastructure. Besides, the mounting adoption rate of claims management systems as a result of the rising number of healthcare facilities within the area has transformed the regional market dynamics. Emerging nations such as India, Japan and China are accountable for the strong adoption of healthcare claims management products and services, contributing immensely to the regional market expansion.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Healthcare Claims Management Market Top Players

The top vendors within the worldwide healthcare claims management market are IBM Corporation (US), Athenahealth (US), Optum, Inc. (US), Accenture Plc. (Ireland), eClinicalWorks (US), Allscripts Healthcare Solutions, Inc. (US), McKesson Corporation (US), nThrive (US), Oracle Corporation (US), Genpact Limited (US), Infor Inc. (US), Conifer Health Solutions (US), Avaya Inc. (USA), Cerner Corporation (US), Cognizant Technology Solutions Corporation (US), among others.

Latest Update

February 2019

Providence Health & Services (US) has acquired Lumedic Inc. (US), which provides platform for revenue cycle management on the basis of machine learning, patient-centric design and blockchain for claims processing.

Arrhythmia Monitoring Devices Market Analysis, Size, Share, Overview, Growth Analysis, Emerging Technologies And Trends By Forecast To 2027

Arrhythmia Monitoring Devices Market Review

Market Research Future (MRFR) on global arrhythmia monitoring devices market reports that the market is expected to attain a CAGR 7.0% during the forecast period of 2018-2023.

Arrhythmia is characterized by the irregular rhythm of heartbeat. The fluctuation in the heartbeat is monitored by the arrhythmia monitoring devices. Tracking heart rhythm in arrythmia patients can assist medical professionals in pre-detection of serious threats. The outstanding benefit of the monitoring devices increasing adoption of arrythmia monitoring devices in several healthcare organizations. This in turn is increasing the arrhythmia monitoring devices sales number. Technical advancements are supporting production of  more efficient arrhythmia monitoring devices. These are the market dynamics which are anticipated to foment the global arrhythmia monitoring device market.

Arrhythmia Monitoring Devices Market Segmental Overview

The global arrhythmia monitoring device market study is segmented into device type, service providers, application, and end use.

Implantable cardiac monitors, mobile cardiac telemetry devices, resting ECG devices, ECG stress test devices, Holter monitors, and others are the arrhythmia monitoring devices market segments, based on the devices type. The ECG and Holter monitor segments are likely to proliferate at an accelerated rate, thereby, contributing to arrhythmia monitoring market growth.

Mobile cardiac telemetry monitoring service providers, independent diagnostic testing facilities/clinics, and others are the market segments, based on the service providers. The emergence of ingenious mobile software that allows connectivity of arrhythmia patients to healthcare professionals is one of the factors expected to boost the service providers segment of the market in the nearing years.  

Bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, conduction disorders, and others are the arrhythmia monitoring devices market segments, based on the application. Owing to the complications associated with the atrial fibrillation several initiatives are being taken like launch of new atrial fibrallation clinic by UNC AFib Care Network in 2018. An upsurge in the atrial fibrillation segment is predicted during 2018-2023.

Hospitals & clinics, ambulatory surgery centers, diagnostic centers, home care settings, long-term care centers, and emergency medical services are the market segments, based on end use.

Arrhythmia Monitoring Devices Market Demographic Insights

The North American region is expected to dominate the arrhythmia monitoring devices market in the upcoming years. Owing to the technical advancement in the US and Canada, they are anticipated to be the regional segments leading the market. Sedentary lifestyle and excessive smoking observed in majority of the North American population are instigating cardiac arrhythmia. This is creating scope for market players to invest in research and developmental activities for improving diagnostic techniques, hence, positively influencing the arrhythmia monitoring devices market in the region.

MRFR envisages Europe to grasp the massive market share during the forecast year of 2018-2023. Increase in cardiac morbidity in the region is triggering the need for designing effective diagnostic techniques and therapies. This is attracting huge investment for research and developmental activities, thereby,  impel the arrhythmia monitoring devices market growth.

Prominent Companies

Cardiac Science Corporation, NUUBO Smart Solutions Technologies, Koninklijke Philips, GE Healthcare, Welch Allyn, Spacelabs Healthcare, Nihon Kohden Corporation, Fukuda Denshi, BioTelemetry, Inc, AliveCor, Inc, Biotronik, Medtronic, Abbott, Applied Cardiac Systems, Aurora Resurgence, iRhythm Technologies, Inc, Medi-Lynx Cardiac Monitoring, Preventive Solutions, Inc. are the important companies operating in the arrhythmia monitoring devices market as mentioned by MRFR.

Browse Full Report with TOC at:

Arrhythmia Monitoring Devices Industry News

February 2019: A new ECG device named HeartCheck Cardi Beat, designed by CardioComm, received FDA clearance. CardioComm, provider of innovative software solutions that specialize in cardiovascular medicine information management system devised HeartCheck Cardi Beat.

Laser Resurfacing Market Analysis By Business Methodologies, Financial Overview And Growth Prospects Predicted By 2027

Laser Resurfacing Market Overview: 

Laser resurfacing, commonly known as laser peel, lasabrasion, or laser vaporization, is a treatment for skin problems like facial wrinkles and acne scars. The process includes a laser beam to remove skin layer by layer. The global laser resurfacing market is fast gaining momentum and can rise with CAGR of 7.1% over the review period of 2017 to 2023. Market Research Future (MRFR) in their latest review of the global laser resurfacing market claims that the probability for the global market to gain acceptance is quite high. 

The laser resurfacing market size is gaining strong traction from skin problems such as acne, wrinkles, skin pigmentation, and surge in intake of minimally invasive medical procedures. Rising expenditure in the healthcare sector is also expected to boost the market growth. But the high cost of treatment for skin diseases can be a hindrance for the market growth. 

Laser Resurfacing Market Competitive Landscape: 

Several companies are expected to launch tactical moves that will include merger, acquisition, product launch, collaboration, and others to ensure their own market position and provide thrust to the holistic growth of the market. These companies are Altair Instruments, Alma Lasers, Lynton Lasers Ltd, Quanta Aesthetic Lasers USA, Lumenis Cynosure, Inc., Lutronic Corporation, Cutera, Syneron Medical Ltd., and Sciton, Inc. MRFR profiled them in their recent report to enable understanding of the global market trends that can impact the laser resurfacing market growth.

Recent reports on laser resurfacing technology promotes an idea of combining this technology with plastic surgery that would help in masking the signs of ageing in a better way.

Laser Resurfacing Market Segmentation: 

The global laser resurfacing market is segmented, as reported by MRFR, on the basis of type, products, indication, and end-user. Such a detailed segmentation holds sway over various factors that can impact the market in the coming years. 

Based on the type, the laser resurfacing market can be segmented into ablative and non-ablative laser resurfacing. The ablative laser resurfacing includes erbium laser resurfacing, CO2 laser resurfacing, and others. The non-ablative laser resurfacing comprises infrared lasers, high impact light sources, fractional laser, and others. All these segments are playing an intrinsic role in taking the global laser resurfacing market forward, which can inspire the global market growth. 

Based on the product, the laser resurfacing market can be segmented into laser skin resurfacing machine, laser tips, CO2 skin laser scanner machine, and others. The laser skin resurfacing machine market is expected to gain robust growth during the forecast period. 

Based on the indication, the laser resurfacing market can be segmented into facial wrinkles, aging, acne scars, skin pigmentation, and others. The ageing segment is gaining substantial boost. The acne scar segment can also fetch in revenue sufficiently. 

Based on the end-user, the laser resurfacing market comprises hospitals, dermatology clinics, home care, and others. Various dermatology clinics are expected to gain high traction. 

Laser Resurfacing Market Regional Analysis: 

Region-specific analysis of the global laser resurfacing market report includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). These four regions would help the global market in gaining strong grounds in the coming years. 

The Americas is leading the market and would retain its market dominance in the coming years. This is due to the acknowledgement of growing number of skin diseases that are getting treated by laser resurfacing treatment. On the other hand, high per capita income and influence of the entertainment industry and social media can ensure better growth rate for the market in the region. The US, Canada, and Mexico, along with Argentina and Brazil from South America are expected to take the market ahead. 

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Europe stands on the second place in the laser resurfacing market owing to a surge in  demand for better diagnostic services. The region would also benefit from increasing investment in the research and development sector. The regional market with countries like Germany, France, and the U.K. fetching revenues substantially, is expected to gain strongly from the market. 

The APAC market is witnessing strong growth in the emerging countries where the healthcare sector is getting revamped and better structured. 

Intravenous (IV) Solution Market Analysis 2021: Key Findings, Regional Analysis, Top Key Players Profiles, Size, Statistics, Industry Growth Rate And Forecasts Till 2027

Intravenous (IV) Solution Market Overview

Intravenous (IV) solutions are fluids that are intended to be injected directly into the venous circulation of individual patients who have deficiency in nutrients or suffer from serious cases of dehydration. The solutions are administered on to the patients whose body nutrients or fluid level falls beneath the standard requirement. These IV solutions are available in the market in various types for usage. Various companies provide packaged intravenous fluids or products to be mixed with sterile water in order to prepare a solution to be administered into the patient.

The global Intravenous (IV) solution market valuation is forecasted to reach USD 11,511.2 million by the end of the review period with a CAGR of 7.69% between 2016 and 2022. As mentioned previously, intravenous solutions are given to patients who are struggling with fluid volume level and deficiency of body nutrients. There are a number of reasons that can cause a drop in the fluid volume. Diarrhea and vomiting are two classic examples of the same, wherein individuals are encouraged to drink more fluids to balance out the electrolytes present in their body. Another cause of fluid volume can be blood loss. As they are consumed directly by the patient during such precarious situation, it is made under very strict regulations by the governments to ensure top-class results and constant availability at clinics, hospitals, and at home. The market demand for this product is surging ahead due to the rising prevalence of chronic diseases and a growing acceptance of Vitamin-C intravenous treatment therapy for treating colorectal cancer.

Intravenous (IV) Solution Market Segmentation

The global intravenous (IV) solution market is segmented in the following basis: type, end-users, and nutritional content.

By type, the market divides in to peripheral parenteral solution and total parenteral solution. With a market share of 66.9% in 2016, the total parenteral solution segment stood as the market dominator. The segment is expected to continue with its period of growth in the forthcoming years as well.

By nutritional content, the market holds carbohydrates, parental lipid emulsion, amino acid solution, vitamins & minerals, and others.

By end-users, the market includes ambulatory, home care, and hospitals and clinics. Hospitals and clinics segment tops the chart with over 40% of the market share under its belt, followed by ambulatory and home care segments, respectively. Both the ambulatory and home care segment will see rapid rise in terms of demand, however, hospitals and clinics segment is expected to hold on to its top position with continued growth and advancement.

Intravenous (IV) Solution Market Regional Analysis

The global intravenous (IV) solution market is growing at a steady pace. The regional market segmentation of intravenous (IV) solutions covers the following regions: Asia-Pacific, North America, Europe, and the Middle East & Africa.

As of 2015, North America held the largest market share of intravenous solutions. The regional market is expected to reach a market valuation of USD 6,543.4 million by the end of the forecast period at 2022. The growing market demand in this region can be attributed to factors such as the increasing acceptance of Vitamin C intravenous therapy treatment for colorectal cancer and the wide-spread prevalence of chronic diseases.

Europe holds the second spot in terms of the market share percentage and is expected to grow at desirable pace of 8.12% CAGR during the forecast period of 2016 to 2022. The Asia-Pacific regional market is believed to be fastest of the lot with a projected CAGR of 8.34% during the review period.

Browse Full Report with TOC at:

Intravenous (IV) Solution Market Competitive Landscape

The intravenous (IV) solution market includes various prominent and leading market players, the names of some of which are mentioned herein: Grifols S.A. (Spain), Fresenius Kabi AG (Germany), ICU Medical, Inc. (U.S.), Terumo Medical Corporation (Tokyo), B. Braun Melsungen AG (Germany), Baxter (U.S.), Amanta Healthcare (India), and others.

February 26th, 2019, Heron Therapeutics, a biotechnology company focused primarily on improving the lives of patients with their best-in-class and innovative treatment proceedings, announced in a statement that the FDA of the US has provided them with the approval for Heron’s supplemental NEW Drug Application for CINVANTI injectable emulsion, for IV usage.

Immunoassay Analyzers Market 2021 Review, Key Players Profile, Statistics, Regional Analysis And Growth By Forecast To 2027

Immunoassay Analyzers Market Scenario

Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimbursement policies may restrain this  growth during the forecasted period. 

Immunoassay Analyzers Market Segmentation

The global immunoassay analyzer market is segmented on the basis of instruments, applications, and end users. On the basis of instruments, the market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others. On the basis of application, the market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others. On the basis of end users, the market is categorized into hospitals, diagnostic laboratories, research institutes, and others. 

Immunoassay Analyzers Market Regional Analysis

The global immunoassay analyzer market is dominated by America, which is followed by Europe. Presence of huge diabetic and cancer population, large geriatric population, and well developed healthcare sector has driven this market’s  growth in America.   Europe immunoassay analyzer market is majorly driven by the presence of large number of pharmaceutical and biotechnological companies. Along with these, Asia Pacific also has the fastest growing immunoassay analyzer market due to rapidly developing economies with huge population base, mainly in India and China. However, the Middle East & Africa has the least market due to limited development in the healthcare sector. 

Some of the major key player of this market are F. Hoffmann-La Roche Ltd.  (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy), and Randox Laboratories Ltd. (UK) 

Access Report Details @

Increasing prevalence of different types of chronic diseases is fueling the growth of this market. The global immunoassay analyzer market is a highly competitive market due to the presence of many small and medium companies. These companies are focusing on the development of new and advances devices, while some companies have adopted strategies of acquisitions and strategic alliances, this will consequently lead to this market’s growth.
Hoffmann-La Roche Ltd, a Swiss multinational healthcare company, operates under two division, which are diagnostics and pharmaceuticals. In 2016, the company launched the new cobas e 801 module, which will help hospitals and laboratories to meet the demand of diagnostic testing. Cobas e 602 is one of the most widely used devices of this company. 

Beckman Coulter, Inc., headquartered in California, US, is a manufacturer of biomedical laboratory instruments. In 2015, the company completed the acquisition of MicroScan from Siemens Healthcare. UniCel DxI 800, UniCel DxI 600, and Access 2 are some of the major immunoassay analyzer manufactured by this  company. 

MEA Smoking Cessation & Nicotine De-Addiction Market In-Depth Analysis & Forecast To 2027

MEA Smoking Cessation & Nicotine De-Addiction Market Overview

The smoking cessation and nicotine de-addiction market in the Middle East and Africa is growing rapidly. Factors such as the increasing desire of addicts to quit smoking and an increasing number of ‘quit smoking’ movements led by the social and health organizations support the growth of the market. Moreover, the increasing or prohibitive costs of tobacco products due to high taxes leveraged and social stigma imposed on tobacco users escalates the market on the larger and widened platform.

Acknowledging the kind of gains the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the Middle East and Africa smoking cessation and nicotine de-addiction market will reach over USD 2108.38 MN, by 2022 registering a significant CAGR of 12.5%. from 2018 to 2022.

In the Middle East, especially in Gulf Cooperation Council (GCC) countries, women and young people have picked up the habit of smoking hookah, a traditional smoking tool known as shishah or nargilah in the Arab world which have given the industry inroads to the two demographic groups that traditionally consume less tobacco.

On the other hand, government initiatives are becoming super successful means to quell the urge among smokers in the MEA region. Through these initiatives, the governments have been taking bold steps towards reducing causalities due to tobacco addiction. The World Health Organization (WHO) has also joined forces with Muslim fundamentalists who condemn smoking as evil.  These movements have gone further by encouraging religious leaders previously not active anti-smokers to take up the cause.

Resultantly, the Tobacco industry has prudently stepped back from religious arguments, and it seems that its hold over Arab smokers is cracking, finally. However, the industry still retains much of its ability to hawk products in Middle Eastern and North African markets.

The inclusion of Nicotine replacement therapy (NRT) in the mainstream de-addiction movement is a progressive move which is having a far-reaching impact on the physical and economic health of these regions. Although NRT (both as gum and a patch format) has been enlisted by the WHO as an Essential Medicine to quit smoking, yet NRT had not been adopted as the first form of treatment.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Middle East and Africa Smoking Cessation & Nicotine De-Addiction Market –   Segments

For ease of understanding, the Middle East and Africa Smoking Cessation & Nicotine De-Addiction Market has been segmented into four key dynamics:

By Treatment                     : Pharmacological and Therapies among others.

By Product Type                : Drugs, Inhalers, Patches, and Sprays & Gums among others.

By Distribution Channel  : Pharmacies, Online, and De-addiction Centers among others.

By Region                            : GCC countries and African countries 

MEA Smoking Cessation and Nicotine De-Addiction Market –   Regional Analysis

Continuing with its dominance, the UAE market for smoking cessation and nicotine de-addiction is estimated to surge, witnessing high consumption of de-addiction products. UAE is expected to create a more significant revenue pocket in the Middle East and Africa market.

The Middle East is a big market for tobacco and its products and accounts for significantly higher smoking rates in the world, but there is growing interest in quitting and an expanding market for de-addiction programs. Middle Eastern and North African governments seem to be vulnerable to the influence of Tobacco.

However, they are proving that this influence they can wield to jarring. They leverage their positions to take up various movements that can help elite to become community pillars to advocate for their interests. Resultant, smoking cessation and nicotine de-addiction products have consistently defended its ample footprint in the Middle Eastern region.

Moreover, the recent decision of the Emirates Authority for Standardization and Metrology (ESMA) to allow the sale of vaping devices is expected to help de-addiction. The major reason behind the move is the growing popularity of the unregulated products available online.

Additional factors such as high disposal income, the presence of plentiful smokers, influence the growth of the regional market, positively. Also, factors such as the continual R&D efforts transpired in the field to bring novelties in the de-addiction products and high per capita income support the growth of the regional market.

The Egypt smoking cessation and nicotine de-addiction products market closely follows the UAE market, accounting for the second-largest market in the MEA region.  Whereas, Algeria and South Africa followed by Ethiopia are emerging as the fastest growing markets in Africa. However, the large unmet medical needs make the rest of Africa market the most prominent one. 

MEA Smoking Cessation & Nicotine De-Addiction Market – Competitive Analysis                    

The smoking cessation and nicotine de-addiction market in the Middle East and Africa appears to be highly competitive with the presence of well-established players having regional as well as global presence. These market players compete against each other on the basis of quality, price, reputation, service, and distribution. Mergers & acquisitions, brand reinforcement, and innovations remain the key strategies adopted by the leading players of the market. The market will witness fierce competition due to the expected product & service extensions and product innovations.

MEA Smoking Cessation & Nicotine De-Addiction Market Major Players:

Key players leading the MEA smoking cessation and nicotine de-addiction market include VMR Products LLC, Pfizer Inc, Johnson & Johnson, Cipla Inc., Novartis International AG, GlaxoSmithKline plc., Nicotek LLC., and Lorillard, Inc. among others.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Industry Advancements/Related News

March 08, 2019 – The Government of India (GoI) introduced Nirmal, a nicotine replacement gum under its Pradhan Mantri Bhartiya Janaaushadhi Pariyojana (PMBJP), strengthening its commitment to fight tobacco addiction in the country.

Launched on the occasion of Janaushadh Diwas (Generic Medicine day), promotion of Nirmal is a bold step by the GOI to achieve the objectives as per India’s National Health Policy 2017. Starting from March 08th, 2019, Nirmal would be available across the country in the Pradhan Mantri Janaushadhi Kendras (PM Generic Medicine Centers).

Neurorehabilitation Devices Market Leading Players, Current Trends, Market Challenges, Growth Drivers And Business Opportunities

Neurorehabilitation Devices Market Analysis  

The global neurorehabilitation devices market is predicted to touch USD 2.25 billion at a 6.3% CAGR over the forecast period (2016-2022), as per the latest Market Research Future (MRFR) report. Neurorehabilitation devices, simply put, are therapeutic devices or handy electronic machines that are used in rehabilitation programs especially for patients that recover from various neurological damages as well as have lost the ability of performing routine activities owing to diseases and injuries such as Parkinson’s disease, epilepsy, brain tumor, stroke, and traumatic brain injury multiple sclerosis. 

In neurorehabilitation, the key focus is on improving the working of the nervous system or looking for new means of attaining the normal function. These devices ensure thorough functional restoration of patients suffering from neurological disorders. The neurorehabilitation process helps in facilitating the reduction in disabilities and impairments, thus ultimately improving the patient’s quality of life.  

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Various factors are propelling the neurorehabilitation devices market growth. These factors, in accordance with the MRFR report, include rising government programs and funding in developing regions for supporting the research and development activities for the creation of new devices, advancements in technology especially in connected and smart devices, proliferation of ubiquitous technologies such as IoT, AI, and AR, and integration of the same in the neurorehabilitation devices. Additional factors pushing market growth include growing prevalence of movement disability that is attributed to different neurological disorders especially stroke and multiple sclerosis, need for comprehensive management, and commercialization of new products. Moreover, improving economic conditions which allow access to quality care and changing lifestyle due to growing industrialization and urbanization are also boosting the market growth.  

On the contrary, high cost of devices, lack of awareness about the advantages and availability of neurorehabilitation devices, and lack of medical practitioners and skilled surgeons in developing countries are factors that may impede the neurorehabilitation devices market growth over the forecast period.  

Neurorehabilitation Devices Market Segmentation  

The MRFR report provides a complete segmental analysis of the neurorehabilitation devices market report on the basis of type, application, and end user.  

Based on product type, the neurorehabilitation devices market is segmented into non-invasive stimulators, brain-computer interface, neuro-robotic devices, wearable devices, and others. Of these, the neurorobotics segment will have the largest share in the market over the forecast period. This is owing to the high availability of prosthetics and exoskeletons to treat movement disabilities.  

Based on end user, the neurorehabilitation devices market is segmented into research institutes, clinics, cognitive care centers, hospitals, and others.  

Based on application, the neurorehabilitation devices market is segmented into Cerebral Palsy, Parkinson’s disease, Schizophrenia, Brain Trauma Injury, Spinal Cord Injury, Stroke, and others.  

Neurorehabilitation Devices Market Regional Analysis  

By region, the neurorehabilitation devices market report covers the latest trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW). Of these, North America will remain the driving force in the market over the forecast period. This is owing to increasing incidences of neurological disorders, technological advancements, growing awareness about the benefits of neurorehabilitation devices, and the presence of well-established healthcare infrastructure.  

The neurorehabilitation devices market in Europe is predicted to have considerable growth over the forecast period. This is owing to government support, favorable government initiatives, a resurging economy, and the proliferation of the healthcare sector. Germany is the chief contributor in the region. 

The neurorehabilitation devices market in the APAC region is predicted to have a lucrative growth over the forecast period. This is owing to the constantly developing healthcare infrastructure and vast development opportunities. Japan, China, and India are the key contributors in this region.  

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Neurorehabilitation Devices Market Key Players

Leading players profiled in the neurorehabilitation devices market report include Tyromotion, St Jude Medical Inc., Neuro Style, Rehabtronics Inc., Rehab-Robotics Company Limited, Hocoma AG, Medtronic, Bionik Labs, MagVenture A/S, Ekso Bionics, Bioxtreme, Ectron Ltd., Denecor, Bioness, Inc., and Helius Medical Technologies. Key market players have embraced vital technologies for enhancing their product portfolios such as robotics, nanotechnology, and Internet of Things.  

Odontogenic Tumor Market 2021 Growth, COVID Impact, Trends Analysis Report 2021

Odontogenic Tumor Market Highlights

The odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are considered to be benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth.  This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period. However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period. The global odontogenic tumor market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position.

Odontogenic Tumor Market Key Players

Some of the key players in the global odontogenic tumor market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec Corporation, Oral health innovation Ltd, Senior Dental Care, LLC, and Amerident Dental Inc.

Odontogenic Tumor Market Regional Analysis

The market in the Americas is expected to dominate the global odontogenic market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities. The Middle East and Africa is anticipated to hold the smallest share of the global odontogenic tumor market. The market growth in this region can be attributed to the increasing healthcare expenditure and lack of awareness among the people regarding odontogenic tumor in children.

Odontogenic Tumor Market Segmentation

The global odontogenic tumor market is segmented into types of tumor, diagnosis, treatment, and end-user. Based on types of tumor the odontogenic tumor market is segmented into two segments, namely,  malignant odontogenic tumors and benign odontogenic tumors. Malignant odontogenic tumors are further sub-segmented into ameloblastic carcinoma, primary intraosseous carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and odontogenic sarcomas. Benign odontogenic tumors are further segmented into epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal origin. Epithelial origin is further sub-segmented into ameloblastoma, conventional, squamous odontogenic tumor, calcifying epithelial odontogenic tumor, and adenomatoid odontogenic tumor. Mixed (Epithelial-Mesenchymal) origin is further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor, odontoma, and dentinogenic ghost cell tumor. 

Access Report @

Mesenchymal origin is further sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma, cementoblastoma, and cemento-ossifying fibroma. On the basis of diagnosis, the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy. Based on end-user, the odontogenic tumor market is further segmented into hospitals, dental clinics, dental laboratories, dental academics, and research institutes.

Occlusion Devices Market Scenario Highlighting Major Drivers & Trends, 2023

Occlusion Devices Market – Overview

The growth in the demand for diagnostic has had a beneficial effect on the growth of the market for occlusion devices. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is projected to attain a CAGR of 6.1% in the forecast period.

The rise in heart-related ailments has been identified as a vital factor for the development of the occlusion devices market size. The increased prevalence of chronic diseases is also expected to benefit the demand for occlusion devices. Also, an increased pace of improvement in the product design and efficiency of occlusion devices is projected to create favorable opportunities for expansion.

Occlusion Devices Market Competitive Analysis

The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period. The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans.

The prominent contenders in the occlusion devices market are Acrostak, Cook Group, Angiodynamics, Asahi Intecc, Avinger, Cardinal Health, Edwards Lifesciences,  Terumo Corporation (Japan), Penumbra, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG (Germany), Abbott Laboratories (U.S.), Medtronic plc (Ireland), MicroPort Scientific Corporation (China) and Meril Life Sciences Pvt. Ltd. (India) to name a few.

Occlusion Devices Market Segmental Analysis

The segmental analysis of the occlusion devices market is carried out on the basis of product, region, application, and end-user. Based on the product, the occlusion devices market is segmented into support devices, tubal occlusion devices, support devices, and occlusion removal devices. The embolization devices segment is further segmented into tubal occlusion devices and liquid embolic agents. The occlusion removal devices are further segmented into stent retrievers, coil retrievers, balloon occlusion devices, and suction and aspiration devices. The support devices segment is further segmented into guidewires and microcatheters. The segmentation of the occlusion devices market based on application comprises of cardiology, neurology, peripheral vascular diseases, oncology, urology, gynecology, and others. The end-user based segmentation of the occlusion devices market comprises of diagnostic centers, hospitals and clinics, ambulatory care centers, surgical centers, and others.

Obtain Premium Research Report Details @

Occlusion Devices Market Regional Analysis     

The regional analysis of the occlusion devices market observes that the North American region is the chief region and is chiefly motivated by the mounting patient population suffering from persistent diseases, rising investment in healthcare, and escalating geriatric population levels. Also, the U.S. is the principal market in the North American region due to the incidence of a huge number of market companies manufacturing occlusion devices and growing awareness about risk factors for chronic diseases. The European region’s occlusion devices market shows positive growth with an escalating emphasis on the diagnosis of chronic diseases and other associated diseases. The Asia Pacific region is anticipated to be the top growing market whose expansion is accredited to the mounting burden of chronic diseases and escalating focus on early diagnosis and management of heart diseases. Additionally, other factors contributing to the expansion of the occlusion devices market are lifestyle changes, the control of western culture among adults, and compulsion to smoke. The Middle Eastern and African region in the market for occlusion devices displays a stable rise with a boost in the number of healthcare facilities offering treatment of chronic circumstances and the affluent growth in the medical device sector, particularly in the devices used in treatment methods.

Create your website with
Get started